C07D 215/60
N-oxides
C07D215/60 (N-oxides) appears on 94 US grants and 84 published applications in this corpus.
Search patents in C07D- Granted patents
- 94
- Published applications
- 84
- Assignees
- 83
- Inventors
- 408
- Latest grant
- 19 Nov 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 2 |
| 2004 | 2 | 3 |
| 2005 | 0 | 2 |
| 2006 | 2 | 4 |
| 2007 | 2 | 7 |
| 2008 | 1 | 6 |
| 2009 | 3 | 4 |
| 2010 | 1 | 4 |
| 2011 | 2 | 1 |
| 2012 | 2 | 7 |
| 2013 | 3 | 3 |
| 2014 | 6 | 8 |
| 2015 | 8 | 8 |
| 2016 | 6 | 10 |
| 2017 | 4 | 4 |
| 2018 | 3 | 0 |
| 2019 | 5 | 2 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 2 |
| 2024 | 0 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents19 Nov 2019US 10,479,765 B2Bayer Pharma Aktiengesellschaft
- Nitrocatechol derivatives as COMT inhibitors2 Jul 2019US 10,336,740 B2Bial - Portela & Ca, S.A.
- Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide30 Apr 2019US 10,273,211 B2Exelixis, Inc.
- Compounds for inhibiting drug-resistant strains of HIV-1 integrase19 Feb 2019US 10,208,035 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents29 Jan 2019US 10,189,788 B2Bayer Pharma Aktiengesellschaft
- Desidustat particles and compositions thereof12 Dec 2024US 2024/0408022 A1Zydus Lifesciences Limited
- A quinolone compound in solid forms and processes for the preparation thereof12 Sep 2024US 2024/0300899 A1
- Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide29 Aug 2024US 2024/0287002 A1Exelixis, Inc.
- Heteroaryl compounds for the treatment of pain30 Nov 2023US 2023/0382910 A1Vertex Pharmaceuticals Incorporated
- Biaminoquinolines and nanoformulations for cancer treatment2 Nov 2023US 2023/0348419 A1The Regents of the University of California
Most cited
By later US patents
- Hetaroyl cyclohexanedione derivatives with herbicidal effect60US 6,479,436 B1BASF SE · 2002
- Therapeutic uses of tri-aryl acid derivatives55US 7,005,440 B1Aventis Pharma Deutschland GmbH · 2006
- 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives45US 4,625,034 AUSV Pharmaceutical Corporation · 1986
- Quinoline and cinnoline fungicide compositions44US 5,240,940 ADowElanco · 1993
- Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors44US 8,071,616 B2Bayer HealthCare LLC · 2011